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Abstract
Background:  During natural fertilization, sperm fusion with the oocyte induces long lasting
intracellular calcium oscillations which in turn are responsible for oocyte activation. PLCZ1 has
been identified as the factor that the sperm delivers into the egg to induce such a response. We
tested the hypothesis that PLCZ1 cRNA injection can be used to activate bovine oocytes.
Results: Mouse and bovine PLCZ1 cRNAs were injected into matured bovine oocytes at different
concentrations. Within the concentrations tested, mouse PLCZ1 injection activated bovine
oocytes at a maximum rate when the pipette concentration of cRNA ranged from 0.25 to 1 µg/µL,
while bovine PLCZ1 was optimal at 0.1 µg/µL. At their most effective concentrations, PLCZ1
induced parthenogenetic development at rates similar to those observed using other activation
stimuli such as Ionomycin/CHX and Ionomycin/DMAP. Injection of mouse and bovine PLCZ1
cRNA induced dose-dependent sperm-like calcium oscillations whose frequency increased over
time. Injection of bovine and mouse PLCZ1 cRNA also induced IP3R-1 degradation, although
bovine PLCZ1 cRNA evoked greater receptor degradation than its mouse counterpart.
Conclusion: Injection of PLCZ1 cRNA efficiently activated bovine oocytes by inducing a sperm-
like calcium oscillatory pattern. Importantly, the high rate of aneuploidy encountered in
parthenogenetic embryos activated by certain chemical means was not observed in PLCZ1
activated embryos.
Background
Ovulated mammalian oocytes are arrested at the met-
aphase II (MII) stage of meiosis and only complete meio-
sis after fertilization. The sperm is responsible for
releasing the oocyte from its meiotic arrest, and also for
inducing other events that are collectively referred to as
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oocyte activation. Oocyte activation events include corti-
cal granule exocytosis, reinitiation of meiosis, extrusion of
the second polar body, formation of pronuclei, and
recruitment of mRNA [1,2]. In all mammalian species
studied so far, oocyte activation is triggered by repetitive
rises in the intracellular concentration of free Ca2+
([Ca2+]i) [3], a sufficient and indispensable event [4]. The
[Ca2+]i rises are generated by release of Ca2+ from the intra-
cellular stores, which is mediated by production of inosi-
tol 1,4,5-triphosphate (IP3) following activation of the
phosphoinositide signaling pathway [5,6].
It is hypothesized that upon fusion with the oocyte the
sperm introduces a protein factor responsible for inducing
production of IP3 and Ca2+ release. A growing body of evi-
dence suggests that the sperm factor is phospholipase C-
zeta (PLCZ1) [7]. This PLC variant is sperm specific [8]
and induces sperm-like [Ca2+]i oscillations when injected
into mouse oocytes [9]. Injection of cRNA coding for
PLCZ1 into mature mouse [8], human [10], and pig [11]
oocytes induces [Ca2+]i oscillations and oocyte activation.
In mouse sperm, PLCZ1 localizes to the postacrosomal
region [9], the area thought to first interact with the
oocyte membrane [12]. Functional studies using RNAi to
reduce the level of PLCZ1 in sperm showed that [Ca2+]i
oscillations were reduced after intracytoplasmic sperm
injection (ICSI) and a lower number of progeny was
obtained after natural mating [13]. Finally, in fractiona-
tion studies, the presence of immunoreactive PLCZ1 cor-
related with the ability of fractions to induce oocyte
activation [9], and immunodepletion of PLCZ1 from
sperm extracts suppressed its [Ca2+]i oscillation-inducing
ability [8]. Altogether, this evidence suggests that PLCZ1 is
the factor responsible for oocyte activation in mammals.
PLCZ1, like other PLCs, catalyzes the hydrolysis of phos-
phatidyl 4,5-bisphosphate (PIP2), producing IP3 and 1,2-
diacylglycerol (DAG). The elevation in IP3 concentration
is responsible for inducing Ca2+ release from the endo-
plasmic reticulum (ER), the Ca2+ store of the cell, upon
binding its cognate receptor, IP3R-1, which is mostly
located in this organelle. Continuous production of IP3 is
thought to underlie the persistence of the oscillations dur-
ing mammalian fertilization [7,14,15], and eventually
lead to IP3R-1 degradation [16,17]. IP3R-1 downregula-
tion, which is a hallmark of fertilization, is thought to
contribute to the decreased responsiveness to IP3 observed
after fertilization [18]. Importantly, while PLCZ1 has been
shown to trigger [Ca2+]i oscillations, whether or not it is
capable of inducing IP3R-1 degradation has not been pre-
viously reported.
Parthenogenesis is the development of an embryo with-
out paternal contribution [19]. When placed in the uterus
of a surrogate mother, mammalian parthenogenetic
embryos will develop to different stages depending on the
species, but never to term [20]. Bovine oocytes can be par-
thenogenetically activated using ionomycin, ionophore,
ethanol, or electric stimuli [21]. All of these compounds
will trigger a monotonic [Ca2+]i increase that, while neces-
sary, is not sufficient to completely downregulate the
activity of Maturation-Promoting Factor (MPF). To
accomplish this goal, these [Ca2+]i releasing agents must
be used in combination with a protein synthesis or pro-
tein kinase inhibitor such as cycloheximide or 6-dimeth-
ylaminopurine (DMAP), respectively [21]. Using these
activation protocols, parthenotes can reach the blastocyst
stage at reasonable rates; however, the impact these treat-
ments have on in vivo development has not been studied,
mainly because parthenogenetic embryos are inherently
limited in their developmental capacity.
In cattle, PLCZ1 is detected at the equatorial region of
sperm [22], and injection of mouse PLCZ1 cRNA induced
[Ca2+]i oscillations in bovine oocytes [23]. Nevertheless,
the potential of bovine PLCZ1 cRNA to induce [Ca2+]i
oscillations and parthenogenetic activation in homolo-
gous oocytes has not been reported.
In this study, we examined the calcium oscillation-induc-
ing activity of mouse and bovine PLCZ1 cRNA when
injected into bovine oocytes, as well as the effect of their
injection on IP3R-1 concentration. We also compared the
developmental rates of oocytes activated using mouse and
bovine PLCZ1 cRNA to those observed following activa-
tion with commonly used chemical activation procedures.
Lastly, we compared the effect of the activation protocol
on embryo ploidy.
Results
Validation of the intracytoplasmic injection technique for 
bovine oocytes
Intracytoplasmic injections into bovine oocytes represent
a challenge because of the high elasticity of the plasma
membrane and the opacity and darkness of these oocytes.
In this study, we adapted the technique used for ICSI to
inject consistent volumes of PLCZ1 cRNA into bovine MII
oocytes. Using this technique, we were able to inject a pre-
cise amount of media, confident of having penetrated the
plasma membrane. To achieve this, a determined volume
of media was loaded into a Fluorinert-filled pipette using
a hydraulic microinjector. Then, the pipette was advanced
into the oocyte up to about three-quarters of its diameter.
By applying negative pressure, the oocyte cytoplasm was
slowly aspirated. A well-defined meniscus was observed at
the interface of the oocyte cytoplasm and the media when
the plasma membrane was intact. When the plasma mem-
brane was broken, the meniscus disappeared, and the
flow of cytoplasm into the pipette was faster as a conse-
quence of lower resistance. These indicators were used toBMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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determine that the membrane had been penetrated. Then,
applying positive pressure, the cytoplasm was injected
back into the oocyte, followed by the media containing
cRNA (Figure 1a–c). The volume of media injected was
controlled by observing the meniscus at the interface of
media and Fluorinert, guided by the reticulum present in
the microscope's field of view (Figure 1d). According to
our measurements of the internal diameter of the pipette
and the length of the injected column of media, we calcu-
lated that the injection volume would be ~6 pL.
Measuring the diameter of oil drops released in aqueous
media, we calculated an injection volume of 7 ± 0.2 pL
(range 6 to 8.2 pL) (Figure 1e).
To corroborate the efficiency of the injection technique,
we injected Texas Red dextran into the oocytes and then
checked, under fluorescence excitation, the number of
oocytes that had retained the dye. Out of 101 attempted
injections, 99 resulted in successful injection of oocytes
with clear red fluorescence in their cytoplasm (Figure 1f).
Subsequent activation of these oocytes – using ionomy-
cin/DMAP – induced parthenogenetic development at
similar rates to noninjected controls (data not shown).
Moreover, the fluorescence intensity observed in the
oocytes was similar among injected oocytes, indicating
that the volume of media injected was consistent from
oocyte to oocyte (Figure 1f–i). Finally, parthenogeneti-
cally-activated (Ionomycin/DMAP) sham injected oocytes
developed at similar rates than noninjected controls (Fig-
ure 1j).
Activation and parthenogenetic development of bovine 
oocytes injected with PLCZ1 cRNA
We have previously shown that injection of mPLCZ1
(mouse PLCZ1) cRNA into bovine oocytes induces long-
lasting [Ca2+]i oscillations [23]. However, in those studies,
we did not investigate the ability of mPLCZ1 to induce
oocyte activation or parthenogenetic development. In
addition, whether or not injection of bPLCZ1 (bovine
PLCZ) cRNA could replicate the responses induced by bull
sperm was not ascertained. To answer these pending ques-
tions, we first determined whether mPLCZ1 cRNA was
able to induce oocyte activation, which was monitored by
the extrusion of the second polar body. When bovine
oocytes were injected 22 hours after the onset of matura-
tion, extrusion of the second polar body was observed in
all oocytes (n = 13) within five hours of PLCZ1 cRNA
injection. More importantly, rates of oocyte cleavage to
the two-cell stage and pre-implantation embryo develop-
ment to the blastocyst stage were comparable to those
observed for oocytes activated by Ionomycin/DMAP
(Table 1). We next examined whether injection of bPLCZ1
cRNA was able to induce activation and embryo develop-
ment in these oocytes. As shown in Table 2 (tenth dilu-
tions), bPLCZ1 effectively induced activation and embryo
development to the blastocyst stage. We then investigated
whether an association could be established between
cRNA concentrations and high rates of pre-implantation
embryo development. We first examined tenth dilutions
of our cRNA stock, and then refined the concentrations to
obtain maximum embryo development. Among the con-
centrations tested, mPLCZ1 cRNA was most effective
when used at concentrations ranging from 0.25 to 1 µg/µL
(Table 3), whereas bPLCZ1 cRNA was effective at concen-
trations nearly 5-fold lower (Tables 2 and 3). Importantly,
Validation of intracytoplasmic injection technique Figure 1
Validation of intracytoplasmic injection technique. a, 
b, c: Sequence of injection. a) Pipette loaded with Texas Red 
dextran just before injection. b) Pipette advanced into the 
oocyte; cytoplasm is aspirated to break the plasma mem-
brane. c) Aspirated cytoplasm and Texas Red dextran are 
injected into the oocyte. d) Schematic representation of the 
microscope reticulum used as guide to control the injected 
volume. The oocyte is represented in yellow and the pipette 
in blue. The red lines indicate the volume introduced into the 
oocyte which, calculated measuring the pipette internal diam-
eters at both ends, is 5.9 pL. e) An oil drop of the same size 
as the injected volume is shown next to an oocyte. f) 
Oocytes injected using Texas Red dextran. g) From left to 
right, oocyte injected 2X and 1X the normal volume of 
Texas Red dextran. h) Fluorescent intensity profile of the line 
shown in f. i) Fluorescent intensity profile of the line shown 
in g. j) Developmental rates of injected and uninjected bovine 
oocytes after activation using ionomycin/DMAP.
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unlike mPLCZ1, the highest concentrations of bPLCZ1
cRNA tested here had negative effects both on cleavage
and blastocyst rates (Table 2).
With the optimal concentrations of m and bPLCZ1 cRNAs
determined, we investigated whether PLCZ1 cRNAs
induced pre-implantation embryo development to the
blastocyst stage at rates comparable to those induced by
IVF and by frequently used parthenogenetic procedures.
Cleavage and blastocyst rates were similar among parthe-
nogenetic embryos regardless of the activation method
(Figure 2a), and were higher than those achieved by IVF-
derived embryos (P < 0.05). Also, parthenogenetically
activated zygotes consistently cleaved to the two-cell stage
at earlier times than IVF embryos (Figure 2b). Among par-
thenotes, a higher proportion of DMAP-activated
embryos had cleaved by 18 hours postactivation, but no
differences were observed thereafter (Figure 2b). Collec-
tively, our results show that injection of PLCZ1 cRNAs
induces high rates of pre-implantation bovine embryo
development.
Injection of PLCZ1 cRNAs induces [Ca2+]i oscillations and 
IP3R-1 down regulation in bovine oocytes
Our previous finding that concentration and species-of-
origin affect PLCZ1 cRNA's ability to induce embryo
development suggests that the cRNA concentrations
employed in this study might have produced specific
[Ca2+]i responses, as it is well established that too low or
excessive [Ca2+]i stimulation negatively impacts embryo
development [1,24]. We therefore investigated the pattern
of [Ca2+]i oscillations induced by PLCZ1 cRNA injected at
different concentrations. Our results using mPLCZ1
extend our previous findings [23], and show that sperm-
like [Ca2+]i oscillations are observed only during the first
few hours gradually giving way to high frequency [Ca2+]i
oscillations, which likely reflects excessive protein accu-
mulation (Figure 3a). Regarding bPLCZ1, the lowest
cRNA concentration tested (0.1 µg/µL), which promoted
high rates of embryo development, induced oscillations
similar to those triggered by 1 µg/µL mPLCZ1 and,
accordingly, high frequency [Ca2+]i oscillations (less than
three minute intervals) were observed by 5 to 6 hours
post-cRNA injection (Figure 3b). Injection of 1 µg/µL
bPLCZ1 cRNA induced [Ca2+]i oscillations that transi-
tioned into high frequency oscillations by ~3 hours, and
in all evaluated oocytes oscillations had ceased 6 hours
after cRNA injection (Figure 3); this cessation of [Ca2+]i
oscillations was not observed either with 0.1 µg/µL
bPLCZ1 or with 1 µg/µL mPLCZ1 cRNA.
Fertilization-associated [Ca2+]i oscillations are thought to
be underlined by steady production of IP3 [15] that leads
to IP3R-1 down-regulation [17]. Accordingly, we evalu-
ated whether injection of PLCZ1 cRNA resulted in IP3R-1
degradation, and whether IP3R-1 down regulation was
associated with PLCZ1 cRNA concentration and species-
of-origin. We found that injections of 0.1 µg/µL bPLCZ1
or 1 µg/µL mPLCZ1 cRNA induced fertilization-like IP3R-
1 degradation (Figure 4), whereas injection of 1 µg/µL
bPLCZ1 cRNA depleted IP3R-1 from oocytes (Figure 4),
Table 1: Parthenogenetic embryo development induced by injection of mouse PLCZ1 cRNA into bovine oocytes (3 replicates).
Ionomycin/DMAP mPLCZ1
Oocytes (n) 161 123
Cleavage rate1 81 88
Blastocyst rate1 18 23
Blastocyst cell number2 63 ± 16 75 ± 17
1 Percentage from activated oocytes
2 Mean ± standard error
Table 2: Optimization of bovine PLCZ1 cRNA concentration to activate bovine oocytes.
Experiment bPLCZ1 cRNA concentration Replicates Oocytes injected Cleavage Rate1 Blastocyst Rate1
Tenth dilutions 1 µg/µL 3 110 49.1a 12.7a
0.1 µg/µL3 1 1 8 8 7 . 3 b 29.7b
0.01 µg/µL 3 112 69.6a 15.2a
Refined dilutions 0.5 µg/µL 4 144 70.8a 18.8a
0.1 µg/µL 4 154 88.3ab 29.9a
0.05 µg/µL4 1 4 5 8 9 . 0 b 22.8a
a,b: Percentages not sharing a common letter within experiment are statistically different (P < 0.05, Chi-square test).
1 Percentage from activated oocytes.BMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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PLCZ1 cRNA-activated bovine embryos exhibit high 
degree of normal chromosomal composition
Activation of development in oocytes of large domestic
species in the absence of fertilization requires the succes-
sive application of a Ca2+ ionophore followed by incuba-
tion for a few hours with a protein kinase or protein
synthesis inhibitor [21]. While these treatments are highly
effective at inducing pre-implantation embryo develop-
ment, they cause high rates of chromosomal abnormali-
ties [25-27]. Given that we have shown that injection of
PLCZ1 cRNAs dose-dependently induce high rates of par-
thenogenetic pre-implantation development, we asked
whether a higher proportion of these embryos showed
normal chromosomal composition. Accordingly, we com-
pared the chromosomal composition of eight-cell parthe-
nogenetic embryos generated by injection of PLCZ1
cRNAs, versus that of embryos activated by two common
chemical activation procedures, as well as of IVF-derived
embryos (Table 4; Figure 5). Embryos generated using
ionomycin/DMAP showed the highest proportion of
abnormal ploidy (70%), while embryos activated using
ionomycin/cycloheximide showed a modest amount of
aneuploidy (33%) and IVF-derived embryos the least
(6%). PLCZ1 cRNA-activated embryos exhibited the low-
est percentage of aneuploid embryos (25%) among the
parthenogenetic treatments, although it was not signifi-
cantly different than CHX-activated embryos. These
results demonstrate that injection of PLCZ1 cRNA is effec-
tive at inducing development of parthenogenetic embryos
with high rates of normal chromosomal composition.
Discussion
A growing body of evidence supports the view that oocyte
activation during mammalian fertilization is triggered by
the delivery of the sperm-specific PLCZ1 [7]. We show
that expression of both m and bPLCZ1 in bovine oocytes
induces high rates of oocyte activation and pre-implanta-
tion embryo development in vitro by initiating fertiliza-
tion-like [Ca2+]i oscillations in these oocytes. We also
found that lower concentrations of bPLCZ1 than mPLCZ1
cRNA were required to induce [Ca2+]i oscillations and
high rates of parthenogenetic development. Lastly, given
the high proportion of normal chromosomal composi-
tion among embryos activated by injection of PLCZ1
cRNA, this procedure might be more desirable for induc-
ing oocyte activation in assisted reproductive techniques
such as SCNT and ICSI.
PLCZ1 and parthenogenetic development
Our results show that a single injection of m or bPLCZ1
cRNA into bovine oocytes induces rates of oocyte activa-
tion and pre-implantation parthenogenetic development
that are comparable to those observed after chemical acti-
vation. Unlike the most commonly used chemical proce-
dures, where the [Ca2+]i rise induced by ionomycin is
monotonic, and unable to persistently subdue MPF activ-
ity [28], requiring the use of protein synthesis or protein
kinase inhibitors to do so, injection of PLCZ1 cRNA alone
is able to induce all events of oocyte activation. Nonethe-
less, the effectiveness of PLCZ1 cRNA was dose-depend-
ent, with either too low or too high of concentrations
having detrimental effects on embryo development. Thus,
while PLCZ1 cRNA injection may require dose optimiza-
tion for the species of interest, it may serve as an advanta-
geous alternative to chemical activation protocols to
induce parthenogenetic and SCNT embryo development.
Because the normal fertilization [Ca2+]i pattern can be
closely replicated by injection of PLCZ1 cRNA, it would be
possible to discern whether or not reprogramming defects
commonly associated with nuclear transfer-cloning are
related to aberrant [Ca2+]i signaling. In addition, injection
of PLCZ1 cRNA may also be useful to stimulate oocyte
activation and embryo development following bovine
ICSI, given that this procedure is highly inefficient in this
species with the inability of injected sperm to initiate
[Ca2+]i oscillations as one of the underlying problems
[29].
In the present study, cleavage rates and embryo develop-
ment to the blastocyst stage were higher in parthenotes
than in IVF-derived embryos. We speculate that because
all oocytes used for parthenogenetic activation were
Table 3: Optimization of mouse PLCZ1 cRNA concentration to activate bovine oocytes.
Experiment mPLCZ1 cRNA concentration Replicates Oocytes injected Cleavage Rate1 Blastocyst Rate1
Tenth dilutions 0.5 µg/µL 3 123 90.2a 32.5a
0.05 µg/µL 3 112 83.9b 8.9b
0.005 µg/µL 3 122 48.4c 0.8c
Refined dilutions 1 µg/µL 3 107 79.4a 33.6a
0.5 µg/µL 3 112 92.0a 33.9a
0.25 µg/µL 3 110 85.5a 33.6a
a,b,c: Percentages not sharing a common letter within experiment are statistically different (P < 0.05, Chi-square test).
1 Percentage from activated oocytesBMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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denuded prior to activation, which allowed for selection
based on the presence of a polar body and evenly granu-
lated cytoplasm, a higher proportion of developmentally
competent oocytes might have been selected for these pro-
cedures. Conversely, IVF was performed in cumulus-
enclosed oocytes, which might have resulted in fertiliza-
tion of some immature or abnormal oocytes, which inher-
ently have lower developmental competence.
Parthenogenetically activated embryos also cleaved earlier
than IVF-derived embryos. We hypothesize that while in
the case of parthenotes the time of activation is synchro-
nized by ionomycin treatment or injection of PLCZ1
cRNA, sperm entry during IVF takes place within a period
of 6 hours [30]. Interestingly, within the parthenogenetic
procedures, embryos activated with ionomycin/DMAP
cleaved earlier than those activated by ionomycin/
cycloheximide. The basis for this difference remains
unclear, although a more rapid decline in MPF and MAPK
is reportedly associated with the use of DMAP [31].
Parthenogenetic procedures commonly used for bovine
oocytes are associated with high rates of abnormal chro-
mosome composition [25-27]. Moreover, the frequency
of aneuploid embryos was greater when DMAP was used
in the activation protocol [25]; our study showed analo-
gous results. Importantly, injection of PLCZ1 cRNA effec-
tively activated bovine oocytes without causing significant
increase in the frequency of aneuploid embryos when
compared to IVF-derived embryos, as only a quarter of
PLCZ1-activated embryos were tetraploid, which is within
the range of chromosomal abnormalities reportedly
found in bovine IVF embryos (15 to 30 percent) [32,33].
It is worth noting that some tetraploid embryos may arise,
at least in the case of PLCZ1 cRNA injection, as a result of
the use of cytochalasin B, which is required to obtain dip-
loidization of parthenogenetic zygotes; therefore, this
complication is unlikely to be of concern if PLCZ1 cRNA
were to be used in ICSI procedures, which will not require
the use of this drug.
PLCZ1 and [Ca2+]i oscillations in bovine oocytes
Here we show that injection of PLCZ1 cRNAs into bovine
oocytes induced long-lasting [Ca2+]i oscillations that were
similar to those induced by the sperm in this species. The
injection of the PLCZ1 cRNAs was directly responsible for
the [Ca2+]i  responses, as [Ca2+]i  oscillations were pre-
cluded when PLCZ1 cRNA injection took place in the
presence of cycloheximide (data not shown), which
inhibited cRNA translation. Likewise, [Ca2+]i oscillations
were not observed when matured oocytes were injected
with PLCδ1 cRNA, a closely related family member (data
not shown).
In bovine oocytes, fertilization-associated [Ca2+]i oscilla-
tions occur approximately every 20 minutes [34],
although variable [Ca2+]i  oscillations patterns were
observed, with one to five [Ca2+]i transients recorded dur-
ing a 60-minute period [35], possibly due to highly varia-
ble oocyte quality. Injection of PLCZ1 cRNA into bovine
oocytes nearly replicated the sperm-induced [Ca2+]i oscil-
latory pattern, at least for the first few hours after injec-
tion. Inevitably, and regardless of concentration and
species of origin, the frequency of PLCZ1-induced oscilla-
tions increased, with oscillations occurring less than three
minutes apart. This acceleration of oscillations likely
reflects protein accumulation as a result of persistent
translation of the cRNAs and it was most evident after the
PLCZ1 cRNA injection induces bovine parthenogenetic  development at similar rates to common chemical activation  protocols Figure 2
PLCZ1 cRNA injection induces bovine parthenoge-
netic development at similar rates to common 
chemical activation protocols. a) Mean cleavage (open 
bars) and blastocyst (black bars) rates after IVF or partheno-
genetic activation using different methods. Error bar repre-
sents SEM. a, b or y, z: different superscripts represent P < 
0.05. b) Cleavage of embryos after IVF or parthenogenetic 
activation using different methods. Iono = ionomycin; CHX = 
cycloheximide.
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PLCZ1 cRNA injection induces sperm-like calcium oscillations Figure 3
PLCZ1 cRNA injection induces sperm-like calcium oscillations. a) Representative [Ca2+]i profiles. The fluorescence 
intensity ratio at 340/380 nm is plotted over time (minutes after PLCZ1 injection). The number above each graph represents 
the proportion of oocytes analyzed that displayed a similar pattern to that shown. b) Minutes after injection at which the 
[Ca2+]i pattern changed from interspike intervals of > 3 minutes to < 3 minutes for each treatment. Data represented as mean 
± SEM. Different letters indicate P < 0.05.
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injection of high concentrations of bPLCZ1 cRNA. What it
is more, in the latter case, oscillations ceased within six
hours after the injection. The underlying mechanism
responsible for the termination of the oscillations is not
yet clear, although the major downregulation of IP3R-1
observed in these oocytes might be a contributing factor
[17]. Other factors, such as IP3R-1 dephosphorylation
[18,36], or endoplasmic reticulum reorganization [37,38]
cannot be discounted.
The cRNA concentrations that stimulated too low or too
high [Ca2+]i responses produced the lowest cleavage and
developmental rates. These data are consistent with previ-
ous reports in the literature showing the regulatory role of
[Ca2+]i oscillations on the initiation and completion of
oocyte activation events [1,39,40]. For example, it was
shown that fewer number of [Ca2+]i transients are required
to initiate events of oocyte activation than what is
required to complete these events [1]. It is therefore rea-
sonable to speculate that the shorter duration of the
[Ca2+]i  transients observed after injection of 1 µg/µL
bPLCZ1 might have been insufficient to complete all the
oocyte activation events. Alternatively, the overwhelming
stimulation of the phosphoinositide pathway under these
conditions might have also negatively impacted cellular
functions, thereby compromising embryo development.
Importantly, our observation that excessive [Ca2+]i oscilla-
tions induced by injection of bPLCZ1 cRNA result in
lower cleavage rates and embryo development is consist-
ent with previous reports indicating that injection of high
concentrations of PLCZ1 cRNAs into mouse oocytes had
detrimental effects on embryo development [10,41].
The observation that injection of PLCZ1 cRNAs efficiently
induces IP3R-1 degradation in bovine oocytes is consist-
ent with the notion that PLCZ1-initiated [Ca2+]i oscilla-
tions involve the phosphoinositide pathway and IP3
production [42,43], as IP3R-1 degradation requires IP3
binding to its receptor, followed by ubiquitination and
proteasomal degradation of the receptor [44]. It is worth
noting that neither Ca2+ release nor cell cycle progression
induce IP3R-1 degradation in mammalian oocytes
[16,17].
Injection of sperm preparations from a variety of mamma-
lian species triggered fertilization-like [Ca2+]i oscillations
in oocytes from different species, suggesting that the
sperm factor is not species-specific [45-47]. Consistent
with this view, injection of PLCZ1 cRNA coding for the
human, simian, and mouse proteins induced [Ca2+]i oscil-
lations and parthenogenetic development of oocytes from
non-homologous species [41]. Here we extend those
results and show that mPLCZ1 induces [Ca2+]i oscillations
Table 4: Chromosomal composition of parthenogenetic 8-cell embryos activated using different protocols.
Embryos Evaluated Informative embryos 2n 3n 4n Mixoploid (2n/4n) Other Total Abnormal
IVF 22 17 16 (94%) 0 1 (6%) 0 0 1 (6%)a
mPLCZ1 28 16 12 (75%) 0 4 (25%) 0 0 4 (25%)ab
Iono/DMAP 26 20 6 (30%) 0 10 (50%) 2 (10%) 2 (10%) 14 (70%)c
Iono/CHX 28 18 12 (67%) 1 (5%) 5 (26%) 0 1 6 (33%)b
Total 104 71
a,b,c: Percentages not sharing a common letter within experiment are statistically different (P < 0.05, Chi-square test).
A total of 167 metaphases were evaluated (2.3 per informative embryo).
PLCZ1 cRNA injection induces IP3 R-1 downregulation Figure 4
PLCZ1 cRNA injection induces IP3 R-1 downregula-
tion. a) Immunoblot. Five bovine oocytes were used per 
lane; samples were collected 12 hours after cRNA injection. 
MII oocytes were collected at the time of cRNA injection. 
Aged MII are noninjected oocytes that were left in culture 
the same amount of time as the injected ones. bPLCZ1 = 
bovine PLCZ1; mPLCZ1 = mouse PLCZ1. b) Quantification 
of relative abundance of IP3R-1 versus the levels observed in 
MII oocytes. The number in the bars indicates relative IP3R-1 
mass. Data represented as mean ± SEM of two replications. 
Different letters indicate P < 0.06.BMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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and parthenogenetic development in bovine oocytes.
Lower bPLCZ1 cRNA concentrations were required to
induce [Ca2+]i oscillations and activation responses com-
parable to those induced by mPLCZ1 cRNA. Moreover,
the opposite response was observed when m and b PLCZ1
cRNAs were injected in mouse oocytes (data not shown).
There are several possibilities to explain the apparent
higher specific activity of bPLCZ1 cRNA in our studies.
The first possibility is that bPLCZ1 protein exhibits higher
specific activity than mPLCZ1 in bovine oocytes, and this
might be due to higher affinity for the endogenous sub-
strate, or alternatively, because the distribution of bPLCZ1
protein more closely overlaps with that of its substrate. A
second possibility that cannot be discounted is that spe-
cies-specific differences in cRNA translation efficiency
result in higher concentrations of bPLCZ1 protein than
mPLCZ1 protein. Although this is possible, we considered
this possibility improbable as the used cRNAs coded only
for the open reading frame, were produced under identi-
cal conditions and used the same backbone vector.
Regardless, additional in vivo and in vitro studies will be
required to determine which of these possibilities is cor-
rect.
A previous study also compared the oscillatory activity of
different PLCZ1s, but in mouse oocytes [41]. It was shown
that human PLCZ1 was more effective at inducing [Ca2+]i
oscillations in mouse oocytes than simian or mouse
PLCZ1 [41]. Nevertheless, our data represents the first
indication that some PLCZ1 may be more effective within
species than across species. It will be interesting to deter-
mine if gene sequence differences among PLCZ1s from
different species, which are mainly in the inter-domain
regions, the linker region, may play any role in conferring
species-specific adaptations. Therefore, while the mecha-
nism of initiation of [Ca2+]i oscillations in mammals is
highly conserved, adaptations may have occurred during
evolution to carefully orchestrate the early events of
oocyte activation, the appropriate conclusion of which
will impact embryo development to term.
Conclusion
We show that injection of m and bPLCZ1 cRNA into
bovine oocytes induces dose-dependent [Ca2+]i oscilla-
tions, IP3R-1 downregulation and parthenogenetic devel-
opment up to the blastocyst stage. In addition, PLCZ1-
cRNA-activated embryos displayed low levels of aneu-
ploidy. Hence, PLCZ1 cRNA injection represents an effec-
tive tool to activate bovine oocytes and to study the
impact of [Ca2+]i oscillations on mammalian develop-
ment.
Methods
All chemicals were purchased from Sigma (St. Louis, MO)
unless otherwise specified.
Oocyte collection and maturation
Bovine ovaries were obtained from a slaughterhouse and
transported in physiological saline solution in an insu-
lated container. Upon arrival at the laboratory, the ovaries
were rinsed first with warm tap water and then with phys-
iological saline solution. Antral follicles (2 to 8 mm in
diameter) were aspirated using an 18-gauge needle into a
50 mL conical tube by applying 60 mm Hg of negative
pressure using a vacuum pump (Cook, Australia). Cumu-
lus oocyte complexes (COCs), with evenly granulated
oocyte cytoplasm surrounded by more than four compact
layers of cumulus cells, were selected and washed three
times in HEPES-buffered HECM medium [48] (HH; 114
mM NaCl, 3.2 mM KCl, 2 mM CaCl2, 0.5 mM MgCl2, 0.1
mM Na pyruvate, 2 mM NaHCO3, 10 mM HEPES, 17 mM
Na lactate, 1X MEM nonessential amino acids, 100 IU/mL
penicillin G, 100 µg/mL streptomycin, 3 mg/mL BSA).
COCs were then matured in Medium 199 supplemented
with 10 percent FBS (HyClone, Logan, UT), 1 µg/mL of
FSH (Sioux Biochem, Sioux City, IA), 1 µg/mL of LH
Representative chromosomal spreads from 8-cell stage bovine embryos (1000×) Figure 5
Representative chromosomal spreads from 8-cell stage bovine embryos (1000×). a) Diploid cell, b) triploid cell, and 
c) tetraploid cell.
a b c BMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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(Sioux Biochem, Sioux City, IA), 1 µg/mL 17β-estradiol,
2.3 mM of sodium pyruvate, and 25 µg/mL of gentamicin
sulphate (Gibco, Grand Island, NY).
PLCZ1 complementary RNA (cRNA) preparation
A pBluescript vector containing the full-length coding
sequence of murine PLCZ1 or pGEMT-easy vector of
bovine PLCZ1 was linearized with EcoR1 for mouse
PLCZ1 and Sal I for bovine PLCZ1 and used as template
for in vitro transcription by the T7 mMessage mMachine
High Yield Capped RNA Transcription Kit (Ambion, Aus-
tin, TX), following manufacturer instructions. Then, a
poly-A tail was added to the cRNA using the Poly(A) Tail-
ing Kit (Ambion). Finally, the cRNA was purified using
the Mega Clear Kit (Ambion) and stored at -80°C in sin-
gle-use aliquots.
Just before use, the cRNA was thawed on ice, heated to
85°C for three minutes, and centrifuged at 13,000 RPM at
4°C for five minutes. Then appropriate dilutions in
RNAse-/DNAse-free water (Ambion) were prepared.
cRNA microinjection
For cRNA injection, a Petri dish containing a 1 µL drop of
cRNA and a 50 µL drop of HH under mineral oil was
placed on an inverted microscope (TE2000-U, Nikon,
Japan) equipped with micromanipulation equipment
(Narishige, Japan) at room temperature. After removing
the cumulus cells, MII oocytes were placed in the HH
media and injected using a beveled micropipette (5 µm
internal diameter, MIC-50-0, Humagen, Charlottesville,
VA) loaded with Fluorinert, using hydraulic microinjec-
tion equipment (Eppendorf, Westbury, NY). cRNA was
loaded from the tip of the pipette each time before micro-
injection. Then, the pipette was advanced into the oocytes
and the cytoplasm was aspirated by applying negative
pressure to ensure plasma membrane breakage. Finally,
the aspirated cytoplasm, followed by the cRNA, was
injected into the oocyte by applying positive pressure. The
amount of PLCZ1 cRNA injected was controlled by
observing the meniscus at the cRNA-Fluorinert interface.
Intracellular calcium monitoring
Matured oocytes were injected with 0.5 mM Fura-2 dex-
tran (MW 10,000, Molecular Probes, Eugene, OR) as
described for PLCZ1 cRNA. Oocytes were monitored in
groups in 100 µL drops of protein-free TL-Hepes medium
placed on a Petri dish with a glass bottom and covered
with mineral oil. A 75 W Xenon arc lamp provided the
excitation light and excitation wavelengths were of 340
and 380 nm. Wavelengths greater than 510 nm were col-
lected through a 20X objective by Photometrics CCD
SensSys camera (Roper Scientific; Tucson, AZ). Fluores-
cent intensity ratios (340/380 nm) were measured every
twenty seconds for up to three hours using the software
SimplePCI (C-Imaging System, Cramberry Township,
PA).
Western blot of IP3R-1
To assess the down-regulation of IP3R-1 protein, cell
lysates from 5 bovine oocytes (without cumulus cells)
were mixed with 15 µl of 2X SB [49], as described previ-
ously [18], and stored at -80°C. Thawed samples were
boiled for 3 min and loaded onto NuPAGE Novex 3–8%
Tris-Acetate gels (Invitrogen, Carlsbad, CA). After electro-
phoresis, proteins were transferred onto nitrocellulose
membranes (Micron Separations, Westboro, MA). The
membranes were blocked by incubation in PBS contain-
ing 0.1% Tween (PBST) supplemented with 5% non-fat
dry milk for 1.5 h at room temperature and then incu-
bated overnight with a rabbit polyclonal antibody raised
against the C-terminal amino acids 2735–2749 of mouse
IP3R-1 (Rbt03) [50]. The membranes were subsequently
washed in PBST and incubated for 1 h with a goat anti-
rabbit secondary antibody conjugated with horseradish
peroxidase. Membranes were incubated for 1 minute in
cheminoluminescence reagent (NEN Life Science Prod-
ucts, Boston, MA) and developed according to manufac-
turer's instructions. The intensities of IP3R-1 bands were
assessed using a Kodak 440 Image Station (Rochester, NY)
and plotted using Sigma Plot (Jandel Scientific Software,
San Rafael, CA). The intensity of the IP3R-1 band from
bovine MII eggs was given the value of 1 and IP3R-1 abun-
dance in other samples were expressed relative to abun-
dance in MII oocytes.
In vitro fertilization
COCs matured for 24 hours were co-incubated with
sperm (106 spermatozoa/mL) in a fertilization medium
consisting of IVF-TALP (Tyrode's solution) [51] supple-
mented with 10 mM sodium lactate, 1 mM sodium pyru-
vate, 6 mg/ml BSA, 50 µg/mL heparin, 40 µM
hypotaurine, 80 µM penicillamine, and 10 µM epine-
phrine) at 38.5°C in 5% CO2 in air for 20 hours. Pre-
sumptive zygotes were vortexed for two minutes to
separate cumulus cells. Groups of 40 to 50 presumptive
zygotes were cultured in 400 µL drops of KSOM (Chemi-
con, Temecula, CA) supplemented with 3 mg/mL BSA
under mineral oil at 38.5°C, 5% CO2 in air, and humidity
to saturation. Seventy-two hours after insemination, 5%
FBS was added to the culture media.
Parthenogenetic activation
Oocytes that had matured for 20 to 22 hours were sepa-
rated from the surrounding cumulus cells by vortexing in
HH medium containing hyaluronidase (1 mg/mL) for 5
minutes. MII oocytes were selected based on the presence
of a polar body. Twenty-two to 24 hours postmaturation,
oocytes were injected with PLCZ1 and cultured 5 hours in
KSOM containing 7.5 µg/mL cytochalasin B to generateBMC Developmental Biology 2008, 8:16 http://www.biomedcentral.com/1471-213X/8/16
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diploid embryos. For chemical activation the oocytes were
exposed to 5 µM ionomycin (Calbiochem, San Diego,
CA) in HH medium for four minutes, then rinsed three
times in HH medium and allocated to either four hours
culture in 2 mM DMAP in KSOM or six hours culture in
10 µg/mL cycloheximide (CHX) and 5 µg/mL cytochala-
sin B in KSOM. After these treatments, oocytes were rinsed
five times in HH media and cultured as described for IVF
embryos.
Chromosomal Analysis
Seventy-two hours after activation/fertilization, eight-to
sixteen-cell embryos were cultured in KSOM-BSA plus 5%
FBS containing colcemid for 12 to 14 hours. Then,
embryos were exposed to a hypotonic 1% sodium citrate
solution for three to five minutes to induce nuclear swell-
ing. Subsequently, embryos were placed on a clean glass
slide in a small volume of media. A methanol-acetic acid
solution (1:1) was dropped on the embryos while gently
blowing with the slides placed under the stereoscope.
Then, just before the solution dried, another drop of
methanol-acetic acid solution was placed on the embryos
and allowed to dry for at least 24 hours at room tempera-
ture. After drying, slides were stained with 5% Giemsa
solution (Invitrogen, Carlsbad, CA) for ten minutes.
Chromosome spreads were evaluated at ×1000 magnifica-
tion with oil immersion optics (Nikon, Japan). Embryos
were classified as being haploid, diploid, triploid, tetra-
ploid, polyploid, and mixoploid.
Statistical analysis
Cleavage and blastocyst rates were analyzed by chi-square
tests when up to 4 replicates were available. When more
than 4 replicates were performed, cleavage and blastocyst
rate were analyzed using a one-way ANOVA approach in
SAS (Carry, NC), with treatment as fixed effect. Similar
approach was used also to analyze the continuous varia-
bles. Comparisons among treatments were performed
using contrast statements. The proportion of embryos
with abnormal ploidy was analyzed by a chi-square test.
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